Promotion of cooperation between enterprises and the public. Research institutions in R & D & I (Q3304841): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): Development of an integrated workflow for the identification of immune-relevant mutations, synthesis of derived peptides and clinical use of the corresponding neoantigens for novel immunisation strategies in colon and pancreas tumors., translated_summary) |
(Changed label, description and/or aliases in en: translated_label) |
||
| label / en | label / en | ||
Promotion of cooperation between enterprises and the public. Research institutions in R & D & I | |||
Revision as of 17:47, 24 October 2021
Project Q3304841 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Promotion of cooperation between enterprises and the public. Research institutions in R & D & I |
Project Q3304841 in Germany |
Statements
8,373,248.91 Euro
0 references
10,466,561.14 Euro
0 references
80.0 percent
0 references
14 June 2017
0 references
31 May 2023
0 references
Miltenyi Biotec GmbH Niederlassung Teterow
0 references
17166 - Teterow
0 references
Entwicklung eines integrierten Workflows zur Identifikation von immunrelevanten Mutationen, Synthese der abgeleiteten Peptide und klinischen Nutzung der entsprechenden Neoantigene für neuartige Immunisierungsstrategien bei Colon- und Pankreas-Tumoren. (German)
0 references
Development of an integrated workflow for the identification of immune-relevant mutations, synthesis of derived peptides and clinical use of the corresponding neoantigens for novel immunisation strategies in colon and pancreas tumors. (English)
24 October 2021
0 references
Identifiers
DE_TEMPORARY_7626
0 references